Patients' increasing digital participation provides an opportunity to pursue patient-centric research and drug development by understanding their needs. Social media has proven to be one of the most useful data sources when it comes to understanding a company's potential audience to drive more targeted impact. Navigating through an ocean of information is a tedious task where techniques such as artificial intelligence and text analytics have proven effective in identifying relevant posts for healthcare business questions. Here, we present an enterprise-ready, scalable solution demonstrating the feasibility and utility of social media-based patient experience data for use in research and development through capturing and assessing patient experiences and expectations on disease, treatment options, and unmet needs while creating a playbook for roll-out to other indications and therapeutic areas.
CITATION STYLE
Karmalkar, P., Gurulingappa, H., Spies, E., & Flynn, J. A. (2023). Artificial intelligence-driven approach for patient-focused drug development. Frontiers in Artificial Intelligence, 6. https://doi.org/10.3389/frai.2023.1237124
Mendeley helps you to discover research relevant for your work.